EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Locoregional Immune Checkpoint Blockade and Remodeling of Lymph Nodes by Engineered Dendritic Cell‐Derived Exosomes for Suppressing Tumor Progression and Metastasis

Yizhen Wang, Xiaomin Guo, Jingya Qin, Yifan Xue, Peng Zhang, Yadong Liu, Moyang Chen, Guanghao Zhu, Xinqiu Song, Lili Cheng, Bo Liu, Jie Liu iD und 1 weitere

Advanced Science · 2025-06 · 12 (23)

DOI: 10.1002/advs.202500139 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 03.04.2025. Verfasst von Yizhen Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, P. R. China. Hauptthemen laut MEDLINE: Exosomes, Lymph Nodes, Immune Checkpoint Inhibitors, Dendritic Cells. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: High-Tech and Major Technology Projects in Guangzhou, Municipal Schools (Institutes) Joint Funding Project Basic Research Programme, Rural and Social Development Science and Technology Major Programme in Guangzhou.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor‐draining lymph nodes (TDLNs) are the primary sites of eliciting anti‐tumor immunity, which play an important role in controlling tumor progression and metastasis. However, the immunosuppressive microenvironment of TDLNs propels the formation of pre‐metastatic niche, in which the immunocytes are dysfunctional, and the high expression of programmed death‐ligand 1 (PD‐L1) on dendritic cells (DCs) restricts the activation of cytotoxic T lymphocytes. Herein, engineered exosomes (EmDEX@GA) are developed for locoregional immunomodulation of TDLNs. EmDEX@GA possess CC‐chemokine receptor 7 (CCR7) ‐dependent LN homing capacity and over‐expressed programmed cell death protein 1 (PD‐1) for immune checkpoint blockade (ICB). The loaded stimulator of interferon genes (STING) agonist can reinforce anti‐tumor immunity through STING pathway activation. In orthotopic breast cancer mouse model, local administration of EmDEX@GA remodels the immunosuppressive microenvironment of TDLNs and elicits potent anti‐tumor immunity, resulting in the suppression of tumor as well as the reduction of lymph node metastasis and distant metastasis. Compared with systemic ICB, local immunotherapy with EmDEX@GA has better therapeutic efficacy on suppressing distant metastasis. Moreover, the study suggests that the occurrences of distant metastasis are associated with the immunosuppressive microenvironment rather than the metastasis in TDLNs, indicating that targeted immunomodulation of TDLNs is necessary.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesLymph NodesImmune Checkpoint InhibitorsDendritic CellsBreast NeoplasmsAnimalsMiceFemaleTumor MicroenvironmentLymphatic MetastasisHumansImmunotherapyDisease ProgressionCell Line, TumorMice, Inbred C57BL

Stichwörter der Autor:innen

engineered exosomesimmune microenvironmentlocal immunotherapymetastasistumor‐draining lymph nodes

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Ultrasound, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, P. R. China.
  • School of Biomedical Engineering, Sun Yat-sen University, Shenzhen, 518107, P. R. China.
  • Department of Hepatobiliary Pancreatic Splenic Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, P. R. China.

ORCID-Profile: Jie Liu

Förderung

  • High-Tech and Major Technology Projects in Guangzhou
  • Municipal Schools (Institutes) Joint Funding Project Basic Research Programme
  • Rural and Social Development Science and Technology Major Programme in Guangzhou
  • Basic and Applied Basic Research Project of Guangzhou
  • Natural Science Foundation of Guangdong Province
  • Shenzhen Science and Technology Project
  • Five-Year Project of the Third Affiliated Hospital of Sun Yat-Sen University

Zitieren

APA

Wang, Y., Guo, X., Qin, J., Xue, Y., Zhang, P., Liu, Y., Chen, M., Zhu, G., Song, X., Cheng, L., Liu, B., Liu, J., & Ren, J. (2025). Locoregional Immune Checkpoint Blockade and Remodeling of Lymph Nodes by Engineered Dendritic Cell‐Derived Exosomes for Suppressing Tumor Progression and Metastasis. Advanced Science, 12(23). https://doi.org/10.1002/advs.202500139

Vancouver

Wang Y, Guo X, Qin J, Xue Y, Zhang P, Liu Y, et al. Locoregional Immune Checkpoint Blockade and Remodeling of Lymph Nodes by Engineered Dendritic Cell‐Derived Exosomes for Suppressing Tumor Progression and Metastasis. Advanced Science. 2025;12(23). doi:10.1002/advs.202500139

BibTeX
@article{Wang2025,
  author = {Wang, Yizhen and Guo, Xiaomin and Qin, Jingya and Xue, Yifan and Zhang, Peng and Liu, Yadong and Chen, Moyang and Zhu, Guanghao and Song, Xinqiu and Cheng, Lili and Liu, Bo and Liu, Jie and Ren, Jie},
  title = {Locoregional Immune Checkpoint Blockade and Remodeling of Lymph Nodes by Engineered Dendritic Cell‐Derived Exosomes for Suppressing Tumor Progression and Metastasis},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {23},
  doi = {10.1002/advs.202500139}
}
Kostenlos starten →